Ferroptosis and secondary nephrosis
- PMID: 38970511
- PMCID: PMC11208398
- DOI: 10.11817/j.issn.1672-7347.2024.230377
Ferroptosis and secondary nephrosis
Abstract
Secondary nephrosis is a series of chronic kidney diseases secondary to other underlying diseases, mainly manifesting as structural and functional abnormalities of the kidneys and metabolic disorders. It is one of the important causes of end-stage renal disease, with high morbidity and significant harm. Iron is an essential metal element in human cells, and ferroptosis is a non-traditional form of iron-dependent cell death, and its main mechanisms include iron accumulation, lipid metabolism disorders, abnormal amino acid metabolism, and damage to the antioxidant system. Recently studies have found that ferroptosis is involved in the occurrence and progression of secondary nephrosis, and the mechanism of ferroptosis in different secondary nephrosis vary. Therefore, an in-depth and systematic understanding of the association between ferroptosis and secondary nephrosis, as well as their specific regulatory mechanisms, can provide a theoretical basis for the diagnosis, prevention, treatment, and prognosis assessment of secondary nephrosis, laying the foundation for exploring new clinical therapeutic targets for secondary nephrosis.
继发性肾脏病是继发于其他基础疾病的一系列慢性肾脏病,主要表现为肾结构和功能异常、代谢紊乱,是导致终末期肾病的重要原因之一,具有发病率高、危害大等特点。铁是人体细胞中必需的金属元素,铁死亡是一种非传统形式的、铁依赖性的细胞死亡,其主要机制包括铁蓄积、脂质代谢紊乱、氨基酸代谢异常和抗氧化系统损伤。近年研究发现铁死亡参与继发性肾脏病的发生、发展,不同继发性肾脏病中铁死亡的发生机制不同。深入、系统地了解铁死亡与继发性肾脏病之间的关联及其特异性调控机制,可为继发性肾脏病的诊疗、防治及预后评估提供理论依据,为探索继发性肾脏病新的临床治疗靶点奠定基础。.
Keywords: diabetic nephropathy; ferroptosis; hypertensive nephropathy; lupus nephritis; secondary nephrosis.
Conflict of interest statement
作者声称无任何利益冲突。
Similar articles
-
Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.Pharmacol Res. 2024 Apr;202:107139. doi: 10.1016/j.phrs.2024.107139. Epub 2024 Mar 12. Pharmacol Res. 2024. PMID: 38484857 Review.
-
Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications.Front Endocrinol (Lausanne). 2024 Aug 30;15:1447148. doi: 10.3389/fendo.2024.1447148. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39279996 Free PMC article. Review.
-
Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.Metabolites. 2022 Jan 10;12(1):58. doi: 10.3390/metabo12010058. Metabolites. 2022. PMID: 35050181 Free PMC article. Review.
-
Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases.Endocr Metab Immune Disord Drug Targets. 2021;21(5):785-800. doi: 10.2174/1871530320666200731175328. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32735532 Review.
-
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney.Nat Rev Nephrol. 2023 May;19(5):315-336. doi: 10.1038/s41581-023-00689-x. Epub 2023 Mar 15. Nat Rev Nephrol. 2023. PMID: 36922653 Review.
Cited by
-
Regulation of pyroptosis and ferroptosis by mitophagy in chronic kidney disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1769-1776. doi: 10.11817/j.issn.1672-7347.2024.240458. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 40177760 Free PMC article. Review. Chinese, English.
References
-
- 孙伟. 继发性肾病综合征,防患于未然[J]. 江苏卫生保健, 2015, 17(5): 22.
- SUN Wei. Prevention of secondary nephrotic syndrome before it happens[J]. Jiangsu Health Care, 2015, 17(5): 22.
-
- 赵明辉. 全国继发性肾脏病防治学术研讨会纪要[J]. 中华内科杂志, 2001, 40(11): 780-781. 10.3760/j.issn:0578-1426.2001.11.033. - DOI - PubMed
- ZHAO Minghui. Summary of national symposium on prevention and treatment of secondary kidney diseases[J]. Chinese Journal of Internal Medicine, 2001, 40(11): 780-781. 10.3760/j.issn:0578-1426.2001.11.033. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical